Saeidi N, Ansarikojouri M, Mardani M, Rezazadeh R, Goodarzi MK, Amiri F. Enhancing the cytotoxic effects of Carboplatin and Cisplatin on liposomes in oral Cancer cells with Curcumin. Asian Pac J Cancer Biology. 2024;9(4):579–87. https://doi.org/10.31557/apjcb.2024.9.4.579-587.
Ghanbarikondori P, Aliakbari RBS, Saberian E, Jenča A, Petrášová A, Jenčová J, et al. Enhancing cisplatin delivery via liposomal nanoparticles for oral Cancer treatment. Indian J Clin Biochem. 2024. https://doi.org/10.1007/s12291-024-01239-3.
Abedi Cham Heidari Z, Ghanbarikondori P, Mortazavi Mamaghani E, Hheidari A, Saberian E, Mozaffari E, et al. Characteristics and cytotoxic effects of Nano-Liposomal Paclitaxel on gastric Cancer cells. Asian Pac J Cancer Prev. 2023;24(9):3291–6. https://doi.org/10.31557/apjcp.2023.24.9.3291.
Article CAS PubMed PubMed Central Google Scholar
Poy D, Akbarzadeh A, Ebrahimi Shahmabadi H, Ebrahimifar M, Farhangi A, Farahnak Zarabi M, et al. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study. Chem Biol Drug Des. 2016;88(4):568–73. https://doi.org/10.1111/cbdd.12786.
Article CAS PubMed Google Scholar
Semlali A, Beji S, Ajala I, Al-Zharani M, Rouabhia M. Synergistic effects of New Curcumin Analog (PAC) and cisplatin on oral Cancer therapy. Curr Issues Mol Biol. 2023;45(6):5018–35.
Article CAS PubMed PubMed Central Google Scholar
Chang P-Y, Peng S-F, Lee C-Y, Lu C-C, Tsai S-C, Shieh T-M, et al. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells. Int J Oncol. 2013;43(4):1141–50. https://doi.org/10.3892/ijo.2013.2050.
Article CAS PubMed Google Scholar
Mukherjee D, Krishnan A. Therapeutic potential of curcumin and its nanoformulations for treating oral cancer. World J Methodol. 2023;13(3):29–45. https://doi.org/10.5662/wjm.v13.i3.29.
Article PubMed PubMed Central Google Scholar
Talebzadeh H, Talebzadeh M, Satarpour M, Jalali F, Farhadi B, Vahdatpour MS. Enhancing breast cancer diagnosis accuracy through genetic algorithm-optimized multilayer perceptron. Multiscale Multidisciplinary Model Experiments Des. 2024;7(4):4433–49. https://doi.org/10.1007/s41939-024-00487-3.
Ebrahimi P, Karami M, Delavari S, Shojaie L, Hosseini-Berneti S-H, Bayani F, et al. Investigating the mortality trend of gastrointestinal cancers in Babol, North Iran (2013–2021). BMC Gastroenterol. 2024;24(1):100. https://doi.org/10.1186/s12876-024-03189-9.
Article PubMed PubMed Central Google Scholar
Rahimi N, Feizi I, Mashayekhi F, Salehi O, Norouzi F, Iranparvar-Alamdari M, et al. Evaluation of the thyroid and hypothyroid function after postoperative radiation therapy among breast cancer patients. Can Oncol Nurs J. 2024;34(4):477–89. https://doi.org/10.5737/23688076344477.
Article PubMed PubMed Central Google Scholar
Pouyamanesh G, Ameli N, Metanat Y, Khorrami A, Abbasinezhad-Moud F, Qoorchi Moheb Seraj F, et al. Thymol enhances 5-Fluorouracil cytotoxicity by reducing Migration and increasing apoptosis and cell cycle arrest in Esophageal Cancer cells: an In-vitro study. Indian J Clin Biochem. 2024. https://doi.org/10.1007/s12291-024-01219-7.
Rezaei F, Fesharakinia T, Gavanaroudi SB, Rezaeianjam M, Goodarzi MK, Abdollahi M, et al. Utilizing Niosome nanoparticles for the Combined treatment of curcumin and cisplatin in oral Cancer. Asian Pac J Cancer Biology. 2024;9(4):569–77. https://doi.org/10.31557/apjcb.2024.9.4.569-577.
Shakiba D, Shabestari AM, Mokhtari T, Goodarzi MK, Saeed S, Zinatbakhsh Z, et al. Nanoliposomes Meet Folic Acid: A Precision Delivery System for Bleomycin in Cancer Treatment. Asian Pac J Cancer Biology. 2024;9(4):561–8. https://doi.org/10.31557/apjcb.2024.9.4.561-568.
Shafiei Asheghabadi P, Delavari Dosar A, Hashemi M. Mitochondrial RNAs in Oncology: review of interventions and innovative diagnostic approaches in the Biogenesis of Human cancers. Int J BioLife Sci (IJBLS). 2024;3(3):202–7. https://doi.org/10.22034/ijbls.2024.199032.
Bardania H, Tarvirdipour S, Dorkoosh F. Liposome-targeted delivery for highly potent drugs. Artif Cells Nanomed Biotechnol. 2017;45(8):1478–89. https://doi.org/10.1080/21691401.2017.1290647.
Article CAS PubMed Google Scholar
Wang Y, Zhou J, Qiu L, Wang X, Chen L, Liu T, et al. Cisplatin–alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells. Biomaterials. 2014;35(14):4297–309. https://doi.org/10.1016/j.biomaterials.2014.01.035.
Article CAS PubMed Google Scholar
Liao W-T, Chang D-M, Lin M-X, Lee J-W, Tung Y-C, Hsiao J-K. Indocyanine-green-loaded liposomes for photodynamic and photothermal therapies: inducing apoptosis and ferroptosis in Cancer cells with implications beyond oral Cancer. Pharmaceutics. 2024;16(2):224.
Article CAS PubMed PubMed Central Google Scholar
Shtenberg Y, Goldfeder M, Prinz H, Shainsky J, Ghantous Y, Abu El-Naaj I, et al. Mucoadhesive alginate pastes with embedded liposomes for local oral drug delivery. Int J Biol Macromol. 2018;111:62–9. https://doi.org/10.1016/j.ijbiomac.2017.12.137.
Article CAS PubMed Google Scholar
Nguyen H, Nguyen NH, Tran NQ, Nguyen CK. Improved method for preparing cisplatin-dendrimer nanocomplex and its Behavior Against NCI-H460 Lung Cancer Cell. J Nanosci Nanotechnol. 2015;15(6):4106–10. https://doi.org/10.1166/jnn.2015.9808.
Article CAS PubMed Google Scholar
Trang Le NT, Nguyen CK, Nguyen DH. Carboplatin delivery system based on poly(ethylene glycol) methyl ether–cholesterol modified soy lecithin liposomes. Adv Nat Sci Nanosci Nanotechnol. 2020;11(4):045016. https://doi.org/10.1088/2043-6254/abcaf7.
Ghafari M, Haghiralsadat F, Khanamani Falahati-pour S, Zavar Reza J. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy. J Cell Biochem. 2020;121(7):3584–92. https://doi.org/10.1002/jcb.29651.
Article CAS PubMed Google Scholar
Hassanzadeganroudsari M, Heydarinasab A, Akbarzadeh khiyavi A, Chen P, Soltani M. In vitro investigation of anticancer efficacy of carboplatin-loaded PEGylated nanoliposome particles on brain cancer cell lines. J Nanopart Res. 2019;21(6):124. https://doi.org/10.1007/s11051-019-4562-x.
Ullah F, Iqbal Z, Khan A, Khan SA, Ahmad L, Alotaibi A, et al. Formulation Development and characterization of pH Responsive Polymeric Nano-Pharmaceuticals for targeted delivery of Anti-cancer Drug (Methotrexate). Front Pharmacol. 2022;13:911771. https://doi.org/10.3389/fphar.2022.911771.
Article CAS PubMed PubMed Central Google Scholar
Iskandarsyah I, Masrijal CDP, Harmita H. Effects of sonication on size distribution and entrapment of lynestrenol transferosome. Int J Appl Pharm. 2020;12(1):245–7.
Mohammadinezhad F, Talebi A, Allahyartorkaman M, Nahavandi R, Vesal M, Khiyavi AA, et al. Preparation, characterization and cytotoxic studies of cisplatin-containing nanoliposomes on breast cancer cell lines. Asian Pac J Cancer Biology. 2023;8(2):155–9. https://doi.org/10.31557/apjcb.2023.8.2.155-159.
Poy D, Ebrahimi Shahemabadi H, Akbarzadeh A, Moradi-Sardareh H, Ebrahimifar M. Carboplatin liposomal nanoparticles: Preparation, characterization, and cytotoxicity effects on lung cancer in vitro environment. Int J Polym Mater Polym Biomaterials. 2018;67(6):367–70. https://doi.org/10.1080/00914037.2017.1332624.
Das S, Jagan L, Isiah R, Rajesh B, Backianathan S, Subhashini J. Nanotechnology in oncology: characterization and: in vitro: release kinetics of cisplatin-loaded albumin nanoparticles: implications in anticancer drug delivery. Indian J Pharmacol. 2011;43(4):409–13. https://doi.org/10.4103/0253-7613.83111.
Article CAS PubMed PubMed Central Google Scholar
Xiao C-j, Qi X-r, Aini W, Wei S-l. [Preparation of cisplatin multivesicular liposomes and release of cisplatin from the liposomes in vitro]. Yao Xue Xue Bao. 2003;38(2):133–7.
Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release. 2002;79(1):123–35. https://doi.org/10.1016/S0168-3659(01)00530-2.
Comments (0)